Pdt Partners, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Pdt Partners, LLC

$1.02 Billion
Q3 2024

A detailed history of Pdt Partners, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 3,001 shares of REGN stock, worth $2.08 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

3,001

Previous 3,000 0.03%

Holding current value

$2.08 Million

Previous $3.15 Million 0.03%

% of portfolio

0.31%

Previous 0.32%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $1,024 - $1,201	1 Added 0.03%	3,001 $3.15 Million
Q2 2024 Aug 15, 2024	BUY	$883.2 - $1071.19 $2.65 Million - $3.21 Million	3,000 New	3,000 $3.15 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $1.59 Million - $1.94 Million	2,301 New	2,301 $1.89 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $297,560 - $349,215	-500 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $271,740 - $335,485	500 New	500 $316,000
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $237,345 - $280,387	-502 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $224,258 - $275,196	502 New	502 $238,000
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $7.25 Million - $8.76 Million	-13,304 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $8.43 Million - $11 Million	-17,096 Reduced 56.24%	13,304 $8.3 Million
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $470,315 - $691,707	1,399 Added 4.82%	30,400 $14.8 Million
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $1.48 Million - $2.03 Million	-5,404 Reduced 15.71%	29,001 $10.9 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $1.75 Million - $2.04 Million	6,398 Added 22.84%	34,405 $9.54 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $898 - $1,244	3 Added 0.01%	28,007 $8.77 Million
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $3,720 - $4,395	-10 Reduced 0.04%	28,004 $11.5 Million
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $4,365 - $5,239	13 Added 0.05%	28,014 $10.5 Million
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $9.83 Million - $11.4 Million	28,001 New	28,001 $11.3 Million

Others Institutions Holding REGN

# of Institutions

1,526

Shares Held

82.7M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account